Cargando…

Assessing the Implementation of Pharmacogenomic Panel-Testing in Primary Care in the Netherlands Utilizing a Theoretical Framework

Despite overcoming many implementation barriers, pharmacogenomic (PGx) panel-testing is not routine practice in the Netherlands. Therefore, we aim to study pharmacists’ perceived enablers and barriers for PGx panel-testing among pharmacists participating in a PGx implementation study. Here, pharmaci...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Wouden, Cathelijne H., Paasman, Ellen, Teichert, Martina, Crone, Matty R., Guchelaar, Henk-Jan, Swen, Jesse J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141350/ https://www.ncbi.nlm.nih.gov/pubmed/32192029 http://dx.doi.org/10.3390/jcm9030814

Ejemplares similares

Cost-Effectiveness of Pharmacogenomics-Guided Prescribing to Prevent Gene-Drug-Related Deaths: A Decision-Analytic Model
por: van der Wouden, Cathelijne H., et al.
Publicado: (2022)

Implementing pharmacogenomics decision support across seven European countries: The Ubiquitous Pharmacogenomics (U-PGx) project
por: Blagec, Kathrin, et al.
Publicado: (2018)

Pharmacist-Initiated Pre-Emptive Pharmacogenetic Panel Testing with Clinical Decision Support in Primary Care: Record of PGx Results and Real-World Impact
por: van der Wouden, Cathelijne H., et al.
Publicado: (2019)

Technologies for Pharmacogenomics: A Review
por: van der Lee, Maaike, et al.
Publicado: (2020)

Medical education in pharmacogenomics—results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx)
por: Just, Katja Susanne, et al.
Publicado: (2017)

Applying Next-Generation Sequencing Platforms for Pharmacogenomic Testing in Clinical Practice
por: Tafazoli, Alireza, et al.
Publicado: (2021)

Development of the PGx‐Passport: A Panel of Actionable Germline Genetic Variants for Pre‐Emptive Pharmacogenetic Testing
por: van der Wouden, Cathelijne H., et al.
Publicado: (2019)

Estimated nationwide impact of implementing a preemptive pharmacogenetic panel approach to guide drug prescribing in primary care in The Netherlands
por: Bank, P. C. D., et al.
Publicado: (2019)

Translating Pharmacogenomics: Challenges on the Road to the Clinic
por: Swen, Jesse J, et al.
Publicado: (2007)

Application of long-read sequencing to elucidate complex pharmacogenomic regions: a proof of principle
por: van der Lee, Maaike, et al.
Publicado: (2021)

Learning From Consultations Conducted by Community Pharmacists in Northern Ireland for Nonprescription Sildenafil: A Qualitative Study Using the Theoretical Domains Framework
por: Gordijn, Rineke, et al.
Publicado: (2021)

Pharmacogenomic Determinants of Interindividual Drug Response Variability: From Discovery to Implementation
por: Scott, Stuart A., et al.
Publicado: (2021)

Generating evidence for precision medicine: considerations made by the Ubiquitous Pharmacogenomics Consortium when designing and operationalizing the PREPARE study
por: van der Wouden, Cathelijne H., et al.
Publicado: (2020)

The pharmacogenomic landscape of an Indigenous Australian population
por: Samarasinghe, Sumudu Rangika, et al.
Publicado: (2023)

Pharmacogenomic testing in paediatrics: Clinical implementation strategies
por: Barker, Charlotte I. S., et al.
Publicado: (2022)

Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines
por: Manson, Lisanne E. N., et al.
Publicado: (2020)

Pharmacogenomics decision support in the U-PGx project: Results and advice from clinical implementation across seven European countries
por: Blagec, Kathrin, et al.
Publicado: (2022)

Translating pharmacogenomics discoveries into the clinic: an implementation framework
por: Huang, R Stephanie, et al.
Publicado: (2013)

Evaluation of Current Regulation and Guidelines of Pharmacogenomic Drug Labels: Opportunities for Improvements
por: Shekhani, Rawan, et al.
Publicado: (2019)

Phenoconversion of Cytochrome P450 Metabolism: A Systematic Review
por: Klomp, Sylvia D., et al.
Publicado: (2020)

An estimation of patients at potential risk for drug-induced sexual dysfunction using pharmacy dispensing data
por: Gordijn, Rineke, et al.
Publicado: (2020)

First insights into the current practice, knowledge, and attitudes of community pharmacists regarding sexual adverse drug reactions: a cross-sectional survey
por: Gordijn, Rineke, et al.
Publicado: (2023)

Educating the Next Generation of Pharmacogenomics Experts: Global Educational Needs and Concepts
por: Just, Katja S., et al.
Publicado: (2019)

Discriminant content validity of a theoretical domains framework questionnaire for use in implementation research
por: Huijg, Johanna M, et al.
Publicado: (2014)

Development of the pharmacogenomics and genomics literacy framework for pharmacists
por: Rahma, Azhar T., et al.
Publicado: (2021)

Implementation of a Pharmacogenomic Testing Service through Community Pharmacy in the Netherlands: Results from an Early Service Evaluation
por: Thornley, Tracey, et al.
Publicado: (2021)

Assessment of Pharmacogenomic Panel Assay for Prediction of Taxane Toxicities: Preliminary Results
por: Di Francia, Raffaele, et al.
Publicado: (2017)

General practitioners’ everyday clinical decision-making on psychosocial problems of children and youth in the Netherlands
por: van Venrooij, Lennard T., et al.
Publicado: (2022)

Clinical utility of pharmacogenomics in the management of hepatitis C
por: Trinks, Julieta, et al.
Publicado: (2014)

Editorial: The utilization of bench-to-bedside approaches in pharmacogenomics
por: Rytkin, Eric, et al.
Publicado: (2023)

The burden of colorectal cancer survivors in the Netherlands: costs, utilities, and associated patient characteristics
por: Mulder, Frederike E. C. M., et al.
Publicado: (2021)

Patient reporting of sexual adverse events on an online platform for medication experiences
por: Gordijn, Rineke, et al.
Publicado: (2022)

A Review of Mathematical Models for Tumor Dynamics and Treatment Resistance Evolution of Solid Tumors
por: Yin, Anyue, et al.
Publicado: (2019)

Favourable outcomes of a preventive screening and counselling programme for older people in underprivileged areas in the Netherlands: The PRIMUS project
por: van Dijk, D.J. Annemarie, et al.
Publicado: (2017)

A Nanopore sequencing-based pharmacogenomic panel to personalize tuberculosis drug dosing
por: Verma, Renu, et al.
Publicado: (2023)

Measuring determinants of implementation behavior: psychometric properties of a questionnaire based on the theoretical domains framework
por: Huijg, Johanna M, et al.
Publicado: (2014)

Additional Utility of Pharmacogenomics (PGx) Panel Testing in a CYP2D6 Normal Metabolizer with a History of Breast Cancer
por: Schuh, Michael J.
Publicado: (2019)

Comparing outpatient oral antibiotic use in Germany and the Netherlands from 2012 to 2016
por: Gradl, Gabriele, et al.
Publicado: (2018)

Implementation of Pharmacogenomic Clinical Decision Support for Health Systems: A Cost-Utility Analysis
por: Jiang, Shangqing, et al.
Publicado: (2022)

Bereavement in Times of COVID-19: A Review and Theoretical Framework
por: Stroebe, Margaret, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5gkgm73k49n94i739qf1lrqgcn